208 related articles for article (PubMed ID: 17054911)
1. Obestatin does not activate orphan G protein-coupled receptor GPR39.
Lauwers E; Landuyt B; Arckens L; Schoofs L; Luyten W
Biochem Biophys Res Commun; 2006 Dec; 351(1):21-5. PubMed ID: 17054911
[TBL] [Abstract][Full Text] [Related]
2. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?
Gourcerol G; St-Pierre DH; Taché Y
Regul Pept; 2007 Jun; 141(1-3):1-7. PubMed ID: 17321609
[TBL] [Abstract][Full Text] [Related]
3. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.
Zhang JV; Ren PG; Avsian-Kretchmer O; Luo CW; Rauch R; Klein C; Hsueh AJ
Science; 2005 Nov; 310(5750):996-9. PubMed ID: 16284174
[TBL] [Abstract][Full Text] [Related]
4. GPR39 signaling is stimulated by zinc ions but not by obestatin.
Holst B; Egerod KL; Schild E; Vickers SP; Cheetham S; Gerlach LO; Storjohann L; Stidsen CE; Jones R; Beck-Sickinger AG; Schwartz TW
Endocrinology; 2007 Jan; 148(1):13-20. PubMed ID: 16959833
[TBL] [Abstract][Full Text] [Related]
5. Obestatin--a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility.
Gourcerol G; Taché Y
Neurogastroenterol Motil; 2007 Mar; 19(3):161-5. PubMed ID: 17300284
[TBL] [Abstract][Full Text] [Related]
6. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake".
Chartrel N; Alvear-Perez R; Leprince J; Iturrioz X; Reaux-Le Goazigo A; Audinot V; Chomarat P; Coge F; Nosjean O; Rodriguez M; Galizzi JP; Boutin JA; Vaudry H; Llorens-Cortes C
Science; 2007 Feb; 315(5813):766; author reply 766. PubMed ID: 17289961
[TBL] [Abstract][Full Text] [Related]
7. Is GPR39 the natural receptor of obestatin?
Dong XY; He JM; Tang SQ; Li HY; Jiang QY; Zou XT
Peptides; 2009 Feb; 30(2):431-8. PubMed ID: 18977259
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
[TBL] [Abstract][Full Text] [Related]
9. GPR39 receptor expression in the mouse brain.
Jackson VR; Nothacker HP; Civelli O
Neuroreport; 2006 May; 17(8):813-6. PubMed ID: 16708020
[TBL] [Abstract][Full Text] [Related]
10. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39.
Tremblay F; Perreault M; Klaman LD; Tobin JF; Smith E; Gimeno RE
Endocrinology; 2007 Feb; 148(2):501-6. PubMed ID: 17095592
[TBL] [Abstract][Full Text] [Related]
11. Role of the ghrelin/obestatin balance in the regulation of neuroendocrine circuits controlling body composition and energy homeostasis.
Epelbaum J; Bedjaoui N; Dardennes R; Feng DD; Gardette R; Grouselle D; Loudes C; Simon A; Tolle V; Yang SK; Zizzari P
Mol Cell Endocrinol; 2010 Jan; 314(2):244-7. PubMed ID: 19733621
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin and obestatin: different role in fetal lung development?
Nunes S; Nogueira-Silva C; Dias E; Moura RS; Correia-Pinto J
Peptides; 2008 Dec; 29(12):2150-8. PubMed ID: 18789988
[TBL] [Abstract][Full Text] [Related]
13. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
Catalán V; Gómez-Ambrosi J; Rotellar F; Silva C; Gil MJ; Rodríguez A; Cienfuegos JA; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
[TBL] [Abstract][Full Text] [Related]
14. Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.
Kolodziejski PA; Pruszynska-Oszmalek E; Sassek M; Kaczmarek P; Szczepankiewicz D; Billert M; Mackowiak P; Strowski MZ; Nowak KW
J Diabetes; 2017 Apr; 9(4):353-361. PubMed ID: 27106635
[TBL] [Abstract][Full Text] [Related]
15. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents.
De Smet B; Thijs T; Peeters TL; Depoortere I
Neurogastroenterol Motil; 2007 Mar; 19(3):211-7. PubMed ID: 17300291
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of sequence and expression of chicken GPR39.
Yamamoto I; Numao M; Sakaguchi Y; Tsushima N; Tanaka M
Gen Comp Endocrinol; 2007 Mar; 151(1):128-34. PubMed ID: 17239877
[TBL] [Abstract][Full Text] [Related]
17. Obestatin: its physicochemical characteristics and physiological functions.
Tang SQ; Jiang QY; Zhang YL; Zhu XT; Shu G; Gao P; Feng DY; Wang XQ; Dong XY
Peptides; 2008 Apr; 29(4):639-45. PubMed ID: 18325633
[TBL] [Abstract][Full Text] [Related]
18. Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents.
Mondal MS; Toshinai K; Ueno H; Koshinaka K; Nakazato M
J Endocrinol; 2008 Aug; 198(2):339-46. PubMed ID: 18480381
[TBL] [Abstract][Full Text] [Related]
19. The role of the obestatin/GPR39 system in human gastric adenocarcinomas.
Alén BO; Leal-López S; Alén MO; Viaño P; García-Castro V; Mosteiro CS; Beiras A; Casanueva FF; Gallego R; García-Caballero T; Camiña JP; Pazos Y
Oncotarget; 2016 Feb; 7(5):5957-71. PubMed ID: 26716511
[TBL] [Abstract][Full Text] [Related]
20. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E
Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
